These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1352955)

  • 1. Evaluation of anxiolytic action of ondansetron in rats during withdrawal from chronic chlordiazepoxide.
    Rezazadeh SM; Prather PL; Emmett-Oglesby MW; Lal H
    Ann N Y Acad Sci; 1992 Jun; 654():472-3. PubMed ID: 1352955
    [No Abstract]   [Full Text] [Related]  

  • 2. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
    Goudie AJ; Leathley MJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):179-86. PubMed ID: 1979273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abecarnil used to treat benzodiazepine withdrawal.
    Emmett-Oglesby MW; Lytle DA; English SA
    Psychopharmacol Ser; 1993; 11():121-31. PubMed ID: 7908431
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The anxiolytic effect of ondansetron and its capacity to eliminate the benzodiazepine abstinence syndrome in rats].
    Garibova TL; Voronina TA; Kraĭneva VA; Val'dman EA
    Eksp Klin Farmakol; 1999; 62(6):16-9. PubMed ID: 10650519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety.
    Baldwin HA; File SE
    Psychopharmacology (Berl); 1989; 97(3):424-6. PubMed ID: 2497494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal.
    File SE; Zharkovsky A; Hitchcott PK
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):87-93. PubMed ID: 1557510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepoxide withdrawal is not due to enhanced noradrenergic activity.
    Baldwin HA; Hitchcott PK; File SE
    Pharmacol Biochem Behav; 1989 Dec; 34(4):931-3. PubMed ID: 2623049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flumazenil: a possible treatment for benzodiazepine withdrawal anxiety.
    File SE; Baldwin HA
    Lancet; 1987 Jul; 2(8550):106-7. PubMed ID: 2885562
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol.
    de Oliveira Citó Mdo C; da Silva FC; Silva MI; Moura BA; Macêdo DS; Woods DJ; Fonteles MM; de Vasconcelos SM; de Sousa FC
    Behav Brain Res; 2012 May; 231(1):116-23. PubMed ID: 22374255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy and tolerability of clobazam and chlordiazepoxide in the treatment of acute withdrawal from alcohol in patients with primary alcoholism.
    Mukherjee PK
    J Int Med Res; 1983; 11(4):205-11. PubMed ID: 6137426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar effects of ethanol and flumazenil on acquisition of a shuttle-box avoidance response during withdrawal from chronic ethanol treatment.
    Criswell HE; Breese GR
    Br J Pharmacol; 1993 Oct; 110(2):753-60. PubMed ID: 8242248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide.
    Keaney F; Strang J; Gossop M; Marshall EJ; Farrell M; Welch S; Hahn B; Gonzalez A
    Alcohol Alcohol; 2001; 36(5):426-30. PubMed ID: 11524309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam.
    Miklya I; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):561-72. PubMed ID: 2908362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron does not prevent physical dependence in patients taking opioid medications chronically for pain control.
    Chu LF; Rico T; Cornell E; Obasi H; Encisco EM; Vertelney H; Gamble JG; Crawford CW; Sun J; Clemenson A; Erlendson MJ; Okada R; Carroll I; Clark JD
    Drug Alcohol Depend; 2018 Feb; 183():176-183. PubMed ID: 29278818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of nifedipine and chlordiazepoxide on alcohol withdrawal syndrome].
    Samochowiec J; Fabiańczyk K; Reszczyński R; Czopek I; Pełka-Wysiecka J; Horodnicki JM
    Psychiatr Pol; 1996; 30(2):307-20. PubMed ID: 8650291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic characterization of acute chlordiazepoxide dependence in the rat.
    Boisse NR; Periana RM; Guarino JJ; Kruger HS; Samoriski GM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):775-83. PubMed ID: 3098961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.
    Overstreet DH; Knapp DJ; Breese GR
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1473-81. PubMed ID: 17624999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.